SOLENO THERAPEUTICS ($SLNO) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of -$0.95 per share, missing estimates of -$0.95 by ...
SAN FRANCISCO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report ...
OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Soleno Therapeutics, Inc. (“Soleno”) fell over 12% on September 10, 2025, after the company disclosed a patient death involving its treatment for ...
Soleno Therapeutics, Inc. (SLNO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.57 per share a year ago. These ...
Hosted on MSN
Wells Fargo Initiates Coverage of Soleno Therapeutics (SLNO) with Overweight Recommendation
Fintel reports that on August 20, 2025, Wells Fargo initiated coverage of Soleno Therapeutics (NasdaqCM:SLNO) with a Overweight recommendation. Analyst Price Forecast Suggests 74.89% Upside As of ...
SAN FRANCISCO, Aug. 20, 2025 /PRNewswire/ -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report by ...
Soleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs Mura Shares of Soleno Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback